米国における大麻規制の現状:医療用途と嗜好品

  • 富山 健一
    国立精神・神経医療研究センター精神保健研究所薬物依存研究部依存性薬物研究室
  • 舩田 正彦
    国立精神・神経医療研究センター精神保健研究所薬物依存研究部依存性薬物研究室

書誌事項

タイトル別名
  • Present Conditions of Marijuana Regulation in USA: Medical and Recreational Use
  • Symposium Review 米国における大麻規制の現状 : 医療用途と嗜好品
  • Symposium Review ベイコク ニ オケル タイマ キセイ ノ ゲンジョウ : イリョウ ヨウト ト シコウヒン

この論文をさがす

抄録

<p>In most countries marijuana is regulated by the Single Convention on Narcotic Drugs. In Japan marijuana use is illegal under the Marijuana Control Law. In USA, marijuana is also classified as a schedule I drug, which is the most stringent regulation category under federal law. On the other hand, California became the first state to legalize marijuana for medical uses in 1996. Since then, several other US states have approved marijuana for medical or recreational use. However, marijuana remains completely illegal in most states, while some allow only cannabidiol (CBD) extracted from marijuana for medical use. In June 2018, the US Food and Drug Administration approved Epidiolex, the first marijuana-derived drug, containing purified CBD, to treat certain rare childhood seizure syndromes. Therefore the situation surrounding control of marijuana in USA is complex. Recently, a definite trend toward reconsidering marijuana regulation has been seen around the world, which could have a major impact on marijuana policy in Japan. In this review, we investigated existing medical and recreational marijuana laws in various US states, with a focus on California, which approved recreational use in 2018. Here, we describe the current state of marijuana regulation in terms of both medical and recreational use. In addition, we discuss public safety issues associated with marijuana, including crime, traffic accidents, and emergency department visits from possible marijuana exposure, as well as generated tax revenues, from official marijuana-related reports in Colorado, which legalized marijuana use in 2012.</p>

収録刊行物

  • 薬学雑誌

    薬学雑誌 140 (2), 179-192, 2020-02-01

    公益社団法人 日本薬学会

参考文献 (10)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ